Drugs / Genz-644470
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00853242 | Feb → Aug 2009 | chronic renal failure syndrome | Genzyme, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Genz-644470 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00853242 ↗ |
| Route | Oral | “Genz-644470 2.4 g/day tablets dosed orally TID with meals for 3 weeks.” NCT00853242 ↗ |